Table 1 The association between ATAD2 expression and the clinicopathological variables
Variables | Cases | ATAD2 Expression | P | |
|---|---|---|---|---|
Low (%) | High (%) | |||
Gender | 0.514 | |||
Male | 50 | 24 (48.0) | 26 (52.0) | |
Female | 25 | 14 (56.0) | 11 (44.0) | |
Age (years) | 0.134 | |||
< 57 | 39 | 23 (59.9) | 16 (40.1) | |
≥ 57 | 36 | 15 (41.7) | 21 (58.3) | |
Tumor Location | 0.175 | |||
Upper | 9 | 4 (44.4) | 5 (55.6) | |
Middle | 49 | 22 (44.9) | 27 (55.1) | |
Lower | 17 | 12 (70.6) | 5 (29.4) | |
Histologic Grade | 0.624 | |||
G1 | 22 | 13 (59.1) | 9 (40.9) | |
G2 | 33 | 16 (48.5) | 17 (51.5) | |
G3 | 20 | 9 (45.0) | 11 (55.0) | |
T Status | 0.054 | |||
T1–T2 | 19 | 6 (31.6) | 13 (68.4) | |
T3–T4 | 56 | 32 (57.1) | 24 (42.9) | |
Lymph Node Metastasis | 0.002 | |||
N0 | 42 | 28 (66.7) | 14 (33.3) | |
N1,2,3 | 33 | 10 (30.3) | 23 (69.7) | |
TNM Stage | 0.028 | |||
I–II | 36 | 23 (63.9) | 13 (36.1) | |
III–IV | 39 | 15 (38.5) | 24 (61.5) | |
Smoking | 0.253 | |||
No | 25 | 15 (60.0) | 10 (40.0) | |
Yes | 50 | 23 (46.0) | 27 (54.0) | |
Alcohol | 0.423 | |||
No | 44 | 24 (54.5) | 20 (45.5) | |
Yes | 31 | 14 (45.2) | 17 (54.8) | |